DMC Biotechnologies

Revolutionizing the specialty chemical industry by offering sustainable, bio-based ingredients

Director of Analytical Chemistry and Upstream Bioprocess (APR. 2024 – Present)

● Lead and manage 14 employees across the Analytical, Automation, Bioinformatics, and USP teams (up to Associate Director level), fostering collaboration and performance excellence

● Launched and coordinated a cross-functional initiative spanning USP, Analytical, Automation, Bioinformatics, and Metabolic Engineering to standardize workflows and drive organizational alignment

● Led development and qualification of analytical methods alongside scale-up of upstream processes, enabling successful pilot plant transfer

● Designed and implemented a goal-driven performance review and career development framework, strengthening employee growth, engagement, and retention

● Rebuilt and stabilized the Analytical Chemistry team by recruiting key talent, reestablishing team culture, and embedding quality-focused workflows and collaboration practices

● Developed structured systems for scheduling, automated data analysis and quality checks, control charting, and cross-team handoffs to streamline operations and ensure data integrity

● Revamped SOP infrastructure, redesigning templates and overseeing the codification of 71 Analytical and Fermentation processes to enhance compliance and consistency

● Consolidated a fragmented USP data ecosystem into a centralized platform, improving data transparency, scalability, and cross-team decision-making

● Oversaw an AI/LLM integration roadmap to standardize R&D processes, unify data systems, and enable scalable cross-functional analytics

KBI Biopharma

Managed and developed a team of CDMO research associates and scientists responsible for analytical testing of bioprocess development samples

SCIENTIST II (APR. 2023 – Present)

● Experienced in executing and developing methods to assess purity (SEC & RP-HPLC, Capillary Electrophoresis,  charge heterogeneity (IEX-HPLC, icIEF), impurities (HCP & ProA ELISAs, DNA), titer (affinity HPLC),  and glycan profiles (HILIC-UPLC-FLR)

● Lead analytical support for biological programs (MAbs and Fusion proteins) in both early phase (first in human) and late phase (Phase II to PPQ readiness)

● Authored and reviewed protocols, test methods, reports, data summaries and controlled documents in accordance with ICH guidelines and cGMP regulations

● Interfaced with pharmaceutical clients, upstream and downstream product development, and GMP manufacturing to ensure program deliverables and timelines were met

● Expedited timelines by improving data workflows (developed automated assay templates and data analysis reports) and standardized documentation (developed and trained company leads on automated data summary reports created using Visual Basic macros)